menu
    • menu

    Company profile for Genentech

    NEW Drugs in Dev: 179
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medic...
    Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GenentechUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1 DNA Way, South San Francisco, CA 94080
    Telephone
    Telephone
    +1-650-225-1000, +1 (800) 626-3553
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gene.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Roche Halts SMA Drug, Boosting Rivals' Prospects
    Roche Halts SMA Drug, Boosting Rivals' Prospects

    20 Mar 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/roche-ends-run-for-muscular-atrophy-drug-leaving-door-open-for-competitors

    BIOSPACE
    20 Mar 2026
    Share Share
    Genentech Drug Fails Rare Disease Trial, Raises Obesity Risk
    Genentech Drug Fails Rare Disease Trial, Raises Obesity Risk

    20 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/genentech-antibody-fails-boost-muscle-rare-diseases-raising-questions-obesity-trial

    FIERCE BIOTECH
    20 Mar 2026
    Share Share
    Genentech Shreds RIPK1 Inhibitor After Ph. 2 Failure
    Genentech Shreds RIPK1 Inhibitor After Ph. 2 Failure

    19 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/genentech-shreds-ripk1-inhibitor-pipeline-after-early-ph-2-failure

    FIERCE BIOTECH
    19 Mar 2026
    Share Share
    Genentech CEO Says Aiming for Tolerable, Affordable Obesity drugs
    Genentech CEO Says Aiming for Tolerable, Affordable Obesity drugs

    17 Mar 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/genentech-ceo-says-its-flu-medicine-headed-trumprx-2026-03-16/

    REUTERS
    17 Mar 2026
    Share Share
    Genentech Announces Positive Phase II Results for Petrelintide
    Genentech Announces Positive Phase II Results for Petrelintide

    05 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-05/genentech-announces-positive-phase-ii-results-for-petrelintide-an-amylin-analog-developed-for-peopl

    PHARMIWEB
    05 Mar 2026
    Share Share
    Genentech’s Fenebrutinib Shows Phase 3 Success in MS Trials
    Genentech’s Fenebrutinib Shows Phase 3 Success in MS Trials

    02 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-02/genentechs-fenebrutinib-confirms-its-potential-as-first-and-only-btk-inhibitor-for-relapsing-and-pr

    PHARMIWEB
    02 Mar 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Genentech and get a quotation

    Genentech is a supplier offers 6 products (APIs, Excipients or Intermediates).

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN SOUTH SAN FRANCISCO. bulk offered by Genentech

    Find a price of DORNASE ALFA INHALATION SOLUTION (GENENTECH) bulk offered by Genentech

    Find a price of CED88004S bulk offered by Genentech

    Find a price of THROMBOPOIETIN (HUMAN, RECOMBINANT, CHO CELLS, GENENTECH) bulk offered by Genentech

    Find a price of CED88004A bulk offered by Genentech

    Find a price of TUMOR NECROSIS FACTOR RECEPTOR IMMUNOGLOBULIN G bulk offered by Genentech

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search